Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Insulet Corporation

< Previous 1 2 3 Next >
Insulet Announces CFO Transition
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present Extended Real-World Evidence and Best Practices for Optimizing Care with Omnipod® 5
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce Third Quarter 2023 Financial Results on November 2, 2023
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System in Germany
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency1)
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Celebrates One Year of Omnipod® 5 at the American Diabetes Association 83rd Scientific Sessions
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces Omnipod® 5 Automated Insulin Delivery System is Now Available in the United Kingdom
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces New Organizational Structure to Drive Further Growth
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency1)
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Publishes 2022 Sustainability Report Focused on Innovating for the Future and Preserving the Environment
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce First Quarter 2023 Financial Results on May 4, 2023
From Insulet Corporation
Via Business Wire
Tickers PODD
CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (24% constant currency)
From Insulet Corporation
Via Business Wire
Tickers PODD
Highly Anticipated Omnipod® 5 Real-World Evidence to be Presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Acquires Assets of Automated Glucose Control LLC (AGC)
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod® 5 Controller
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Issued Voluntary Medical Device Correction for Omnipod DASH® Personal Diabetes Manager on October 17, 2022
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Reports Third Quarter 2022 Revenue Increase of 24% Year-Over-Year (29% Constant Currency1)
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Recognizes World Diabetes Day and Diabetes Awareness Month Throughout November
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency1)
From Insulet Corporation
Via Business Wire
Tickers PODD
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.